IBDEI1EM ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25178,0)
 ;;=461.9^^145^1536^60
 ;;^UTILITY(U,$J,358.3,25178,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25178,1,4,0)
 ;;=4^461.9
 ;;^UTILITY(U,$J,358.3,25178,1,5,0)
 ;;=5^Sinusitis, Acute
 ;;^UTILITY(U,$J,358.3,25178,2)
 ;;=^259080
 ;;^UTILITY(U,$J,358.3,25179,0)
 ;;=473.9^^145^1536^59
 ;;^UTILITY(U,$J,358.3,25179,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25179,1,4,0)
 ;;=4^473.9
 ;;^UTILITY(U,$J,358.3,25179,1,5,0)
 ;;=5^Sinusitis Chronic
 ;;^UTILITY(U,$J,358.3,25179,2)
 ;;=^123985
 ;;^UTILITY(U,$J,358.3,25180,0)
 ;;=091.0^^145^1536^65
 ;;^UTILITY(U,$J,358.3,25180,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25180,1,4,0)
 ;;=4^091.0
 ;;^UTILITY(U,$J,358.3,25180,1,5,0)
 ;;=5^Syphilis,Primary Genital
 ;;^UTILITY(U,$J,358.3,25180,2)
 ;;=^50581
 ;;^UTILITY(U,$J,358.3,25181,0)
 ;;=097.0^^145^1536^63
 ;;^UTILITY(U,$J,358.3,25181,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25181,1,4,0)
 ;;=4^097.0
 ;;^UTILITY(U,$J,358.3,25181,1,5,0)
 ;;=5^Syphilis,Latent
 ;;^UTILITY(U,$J,358.3,25181,2)
 ;;=^266781
 ;;^UTILITY(U,$J,358.3,25182,0)
 ;;=094.9^^145^1536^64
 ;;^UTILITY(U,$J,358.3,25182,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25182,1,4,0)
 ;;=4^094.9
 ;;^UTILITY(U,$J,358.3,25182,1,5,0)
 ;;=5^Syphilis,Neurosyphilis
 ;;^UTILITY(U,$J,358.3,25182,2)
 ;;=^83026
 ;;^UTILITY(U,$J,358.3,25183,0)
 ;;=097.9^^145^1536^62
 ;;^UTILITY(U,$J,358.3,25183,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25183,1,4,0)
 ;;=4^097.9
 ;;^UTILITY(U,$J,358.3,25183,1,5,0)
 ;;=5^Syphilis NOS
 ;;^UTILITY(U,$J,358.3,25183,2)
 ;;=^116808
 ;;^UTILITY(U,$J,358.3,25184,0)
 ;;=463.^^145^1536^66
 ;;^UTILITY(U,$J,358.3,25184,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25184,1,4,0)
 ;;=4^463.
 ;;^UTILITY(U,$J,358.3,25184,1,5,0)
 ;;=5^Tonsillitis
 ;;^UTILITY(U,$J,358.3,25184,2)
 ;;=^2695
 ;;^UTILITY(U,$J,358.3,25185,0)
 ;;=130.9^^145^1536^67
 ;;^UTILITY(U,$J,358.3,25185,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25185,1,4,0)
 ;;=4^130.9
 ;;^UTILITY(U,$J,358.3,25185,1,5,0)
 ;;=5^Toxoplasmosis NOS
 ;;^UTILITY(U,$J,358.3,25185,2)
 ;;=^120695
 ;;^UTILITY(U,$J,358.3,25186,0)
 ;;=011.90^^145^1536^68
 ;;^UTILITY(U,$J,358.3,25186,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25186,1,4,0)
 ;;=4^011.90
 ;;^UTILITY(U,$J,358.3,25186,1,5,0)
 ;;=5^Tuberculosis
 ;;^UTILITY(U,$J,358.3,25186,2)
 ;;=^122756
 ;;^UTILITY(U,$J,358.3,25187,0)
 ;;=614.2^^145^1536^69
 ;;^UTILITY(U,$J,358.3,25187,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25187,1,4,0)
 ;;=4^614.2
 ;;^UTILITY(U,$J,358.3,25187,1,5,0)
 ;;=5^Tubo-Ovarian Abcess
 ;;^UTILITY(U,$J,358.3,25187,2)
 ;;=^107806
 ;;^UTILITY(U,$J,358.3,25188,0)
 ;;=788.7^^145^1536^72
 ;;^UTILITY(U,$J,358.3,25188,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25188,1,4,0)
 ;;=4^788.7
 ;;^UTILITY(U,$J,358.3,25188,1,5,0)
 ;;=5^Urethral Discharge
 ;;^UTILITY(U,$J,358.3,25188,2)
 ;;=^265872
 ;;^UTILITY(U,$J,358.3,25189,0)
 ;;=131.02^^145^1536^73
 ;;^UTILITY(U,$J,358.3,25189,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25189,1,4,0)
 ;;=4^131.02
 ;;^UTILITY(U,$J,358.3,25189,1,5,0)
 ;;=5^Urethritis, Trichomonal
 ;;^UTILITY(U,$J,358.3,25189,2)
 ;;=^266955
 ;;^UTILITY(U,$J,358.3,25190,0)
 ;;=597.80^^145^1536^74
 ;;^UTILITY(U,$J,358.3,25190,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25190,1,4,0)
 ;;=4^597.80
 ;;^UTILITY(U,$J,358.3,25190,1,5,0)
 ;;=5^Urethritis, Unsp
 ;;^UTILITY(U,$J,358.3,25190,2)
 ;;=^124214
 ;;^UTILITY(U,$J,358.3,25191,0)
 ;;=079.99^^145^1536^78
 ;;^UTILITY(U,$J,358.3,25191,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25191,1,4,0)
 ;;=4^079.99
 ;;^UTILITY(U,$J,358.3,25191,1,5,0)
 ;;=5^Viral Syndrome
